View in EDS HTML Full Text PDF Full Text

Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c).

Saved in:
Bibliographic Details
Title: Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c).
Authors: Fiskus W; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA., Boettcher S; University of Zurich and University Hospital Zurich, CH-8091, Zurich, Switzerland., Daver N; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA., Mill CP; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA., Sasaki K; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA., Birdwell CE; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA., Davis JA; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA., Takahashi K; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA., Kadia TM; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA., DiNardo CD; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA., Jin Q; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA., Qi Y; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA., Su X; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA., McGeehan GM; Syndax Pharmaceuticals, Inc., Waltham, MA, 02451, USA., Khoury JD; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA., Ebert BL; Howard Hughes Medical Institute, Dana-Farber Cancer Institute, Boston, MA, 02115, USA., Bhalla KN; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA. kbhalla@mdanderson.org.
Source: Blood cancer journal [Blood Cancer J] 2022 Jan 11; Vol. 12 (1), pp. 5. Date of Electronic Publication: 2022 Jan 11.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35017466
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Fiskus+W%22">Fiskus W</searchLink>; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA.<br /><searchLink fieldCode="AU" term="%22Boettcher+S%22">Boettcher S</searchLink>; University of Zurich and University Hospital Zurich, CH-8091, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Daver+N%22">Daver N</searchLink>; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA.<br /><searchLink fieldCode="AU" term="%22Mill+CP%22">Mill CP</searchLink>; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA.<br /><searchLink fieldCode="AU" term="%22Sasaki+K%22">Sasaki K</searchLink>; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA.<br /><searchLink fieldCode="AU" term="%22Birdwell+CE%22">Birdwell CE</searchLink>; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA.<br /><searchLink fieldCode="AU" term="%22Davis+JA%22">Davis JA</searchLink>; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA.<br /><searchLink fieldCode="AU" term="%22Takahashi+K%22">Takahashi K</searchLink>; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA.<br /><searchLink fieldCode="AU" term="%22Kadia+TM%22">Kadia TM</searchLink>; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA.<br /><searchLink fieldCode="AU" term="%22DiNardo+CD%22">DiNardo CD</searchLink>; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA.<br /><searchLink fieldCode="AU" term="%22Jin+Q%22">Jin Q</searchLink>; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA.<br /><searchLink fieldCode="AU" term="%22Qi+Y%22">Qi Y</searchLink>; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA.<br /><searchLink fieldCode="AU" term="%22Su+X%22">Su X</searchLink>; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA.<br /><searchLink fieldCode="AU" term="%22McGeehan+GM%22">McGeehan GM</searchLink>; Syndax Pharmaceuticals, Inc., Waltham, MA, 02451, USA.<br /><searchLink fieldCode="AU" term="%22Khoury+JD%22">Khoury JD</searchLink>; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA.<br /><searchLink fieldCode="AU" term="%22Ebert+BL%22">Ebert BL</searchLink>; Howard Hughes Medical Institute, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.<br /><searchLink fieldCode="AU" term="%22Bhalla+KN%22">Bhalla KN</searchLink>; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA. kbhalla@mdanderson.org.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568469%22">Blood cancer journal</searchLink> [Blood Cancer J] 2022 Jan 11; Vol. 12 (1), pp. 5. <i>Date of Electronic Publication: </i>2022 Jan 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568469 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-5385 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220445385%22">20445385 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35017466
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41408-021-00603-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 5
    Titles:
      – TitleFull: Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fiskus W
      – PersonEntity:
          Name:
            NameFull: Boettcher S
      – PersonEntity:
          Name:
            NameFull: Daver N
      – PersonEntity:
          Name:
            NameFull: Mill CP
      – PersonEntity:
          Name:
            NameFull: Sasaki K
      – PersonEntity:
          Name:
            NameFull: Birdwell CE
      – PersonEntity:
          Name:
            NameFull: Davis JA
      – PersonEntity:
          Name:
            NameFull: Takahashi K
      – PersonEntity:
          Name:
            NameFull: Kadia TM
      – PersonEntity:
          Name:
            NameFull: DiNardo CD
      – PersonEntity:
          Name:
            NameFull: Jin Q
      – PersonEntity:
          Name:
            NameFull: Qi Y
      – PersonEntity:
          Name:
            NameFull: Su X
      – PersonEntity:
          Name:
            NameFull: McGeehan GM
      – PersonEntity:
          Name:
            NameFull: Khoury JD
      – PersonEntity:
          Name:
            NameFull: Ebert BL
      – PersonEntity:
          Name:
            NameFull: Bhalla KN
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 11
              M: 01
              Text: 2022 Jan 11
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2044-5385
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Blood cancer journal
              Type: main
ResultId 1